Origins and Development

As long ago as the 18th century, L. Galvani used direct current for medicinal purposes (Galvano Therapy). After having been pushed into the background by chemotherapy and radiotherapy, it has recently returned to the public eye, mainly thanks to studies conducted by R. Pekars, because the newly refined percutaneous (through the skin)  bio-electrotherapy offers an economical, low risk alternative with a high success rate.  It has been a part of Hans Peter Weber’s therapy program since the 1990s.

Starting Point and Methodological Principle

Tumour development, says Weber, is the result of a long-standing immune deficiency caused by multiple influences.  This has therefore to be borne in mind when beginning a treatment and the “human being as a whole” has to be treated both from a physical and from a psychological point of view. “Electrotherapy” makes use of the altered electrical resonance of the tumour cells.

With ECT, the aim is to achieve  “the intentional, fast, aseptic bio-necrosis (sterile dying-off) of a tumour or of a tumour field by means of a controlled, gradual, switchable source of direct current using electrode probes in and on the tumour tissue”. Due to the very much lower electrical resistance of malignant cells compared to healthy cells, it is possible to force an ionic transport. Depolarisation of the cell membrane comes about and disturbances in the metabolism and in individual intercellular structures are the result.  In the environment of both electrodes (cathode, anode) a pH-value shift comes about which destroys tissue and an increased ion acceleration perforates the membrane. This provides a target for the phagocytes (scavenger cells of the immune system). At the same time, tumour antigens are released and increasingly recognized by the attracted immune cells. A new formation of metastases is therefore effectively counteracted.

Spectrum and Procedure of Treatment

ECT is suitable for all tumours, which can be accessed by needle electrodes and pad electrodes and which are not electro-repellent. First, a sterile covering is placed on the part of the body to be treated, which is anaesthetised.  The success of the out-patient treatment also depends on the analysis of the tumour’s nature, and on the treatment procedure which is exactly designed in accordance with the analysis. The treatment is steered, controlled and documented by computer. During the placement of the electrodes, the current is already active, in order to bind any tumour cells which may have been detached in the tumour field. As a rule, a period of up to three hours is sufficient to cause a gradual dying-off of the tissue.

Forecast

Studies at home and abroad support the positive effect of this  side-effect free method of combating tumours  - in particular for example in China with a healing success rate of up to 80%.  Why not fall back on this treatment when conventional methods are much more radical and often cannot promise complete healing? Hans Peter Weber says: “The person who heals is in the right” and  is pleased to provide support and advice to all who are interested in ECT in a non-binding consultation with detailed information documentation.